Presently, Joseph M. Miller holds the position of Chief Financial Officer for Aurinia Pharmaceuticals, Inc. Mr. Miller is also on the board of Avalo Therapeutics, Inc.

In his past career Mr. Miller was Chief Financial Officer & Vice President-Finance for Eppendorf-5 Prime, Inc., Senior Director-Accounting at Qiagen Genomics, Inc. and Vice President-Finance for Sucampo Pharmaceuticals, Inc.

He received an undergraduate degree from Villanova University.